INTRODUCTION {#SEC1}
============

The potential for misincorporation of ribonucleotides (rN) into DNA and 2′-deoxyribonucleotides (dN) into RNA has long been recognized as a possible consequence of the ability of polymerases to discriminate among components of the highly dynamic nucleotide pool in prokaryotic and eukaryotic cells in different environments ([@B1]--[@B3]). A key discriminatory feature here is the 2′-OH in RNA that plays critical roles in protein--RNA recognition ([@B4]), stabilization of RNA structures ([@B5]--[@B7]), RNA packing ([@B8]) and RNA-mediated catalysis ([@B9]), among other processes. A single dN substitution at random or specific sites in RNA can significantly affect these processes ([@B5],[@B9]--[@B11]) by perturbing both single- and double-stranded RNA structures ([@B5]). The incorporation of dN into RNA can have a variety of deleterious consequences for cells and RNA viruses. For example, it has been shown that mutation of residues involved in discrimination against dNTPs in RNA polymerases can cause growth defects and lethality in cells and viruses ([@B12],[@B13]). Furthermore, dNs inserted by cellular and viral RNA polymerases impede further extension of a transcript ([@B14]--[@B16]). Beyond the obvious miscoding effects of dN in mRNA, incorporation of dN at specific sites in rRNAs and tRNA has been shown to significantly alter critical steps in translation ([@B10],[@B17]--[@B22]), including tRNA binding to the ribosome, translocation and elongation. Such alterations may trigger ribosomal frameshifting ([@B23]) or result in the production of prematurely terminated peptides, which has been implicated in neurodegenerative and other diseases ([@B24]). dN in RNA also has implications for replication of viral RNA genomes and reverse-transcription of retroviruses, with *in vitro* studies revealing problems with initiation and completion of these two processes when RNA-dependent RNA polymerases (RdRPs) and HIV-1 reverse transcriptase were presented with dN-containing RNA templates ([@B15],[@B25]--[@B29]). The presence of dN in viral RNA genomes thus has the potential to both alter the rate of viral evolution by mutation and cause genome truncation that is associated with persistent viral infections ([@B30]).

In spite of the many potentially deleterious consequences of the presence of dN in coding and non-coding RNAs, this phenomenon is largely unexplored *in vivo* due to a lack of appropriate tools for quantitative analysis of dN in RNA. Our understanding of the mechanisms contributing to dN incorporation into RNA is based on numerous *in vitro* studies of RNA polymerase incorporation of dNs during RNA synthesis and the potential for dN incorporation in cells with defined nucleotide pool imbalances. In general, the concentrations of ribonucleotide triphosphates (NTP) range from ∼1000 to ∼3000 μM in cells while 2′-deoxynucleotide triphosphates (dNTP) are ∼10-fold lower in concentration, ranging from ∼100 to ∼300 μM (examples in Table [1](#tbl1){ref-type="table"}) ([@B31]--[@B34]). Large shifts in these concentrations can occur under a variety of genetic and environmental conditions, such as loss of nucleoside diphosphate kinase (Ndk) *E. coli* (Table [1](#tbl1){ref-type="table"}), an enzyme that converts (d)NDPs to their corresponding triphosphates ([@B35]). For reasons that are not entirely clear, loss of *ndk* disrupts the (d)NTP pool balance to cause large increases in dCTP concentrations ([@B33]). In the context of RNA polymerase activity, the active sites of most, if not all, RNA polymerases have evolved to efficiently exclude dNTPs during RNA synthesis ([@B1]). However, dNTP exclusion is not absolute ([@B1]). Kinetic studies ([@B14],[@B16],[@B36]--[@B38]) have revealed that the degree of selectivity for insertion of rNTPs over dNTPs into RNA varies from ∼30- to ∼5000-fold, depending upon the RNA polymerase and the rNTP/dNTP pair examined. The probability of dN incorporation during RNA synthesis is reduced by the fact that the concentrations of dNTPs *in vivo* are lower than the concentrations of rNTPs by orders-of-magnitude ([@B3]) (Table [1](#tbl1){ref-type="table"}). There is also evidence that DNase I can cleave dN-containing RNA *in vitro* ([@B39]) that raises the possibility of a surveillance mechanism *in vivo*.

###### Concentrations of ribonucleotides and 2′-deoxyribonucleotides in *E. coli*

  (d)NNP   Wild-type^1^ (μM)   Wild-type^2^ (μM)   Δndk^3^ (μM)
  -------- ------------------- ------------------- --------------
  ATP      3560                                    
  ADP      116                                     
  dATP     181                 205                 110
  CTP      325                                     
  dCTP     184                 475                 7455
  GTP      1660                                    
  GDP      203                                     
  dGTP     92                  95                  440
  UTP      667                                     
  UDP      54                                      
  dTTP     256                 420                 580

^1^*E. coli* MG1655 ([@B31]).

^2^*E. coli* JC7623; average of data from two publications ([@B32],[@B33]).

^3^*E. coli* QL7623; average of data from two publications ([@B32],[@B33]).

Here, we present the development and application of a method to quantify dN incorporation into any form of RNA from any organism. The platform combines alkaline hydrolysis of RNA to yield dNrN dinucleotides that are then quantified by chromatography-coupled tandem mass spectrometry (LC-MS/MS). Analysis of coding and non-coding RNAs from human, yeast and bacterial cells, and an RNA virus, reveals highly abundant dN incorporation that varies as a function of the identity of the polymerase, environmental stresses, and nucleotide pool balance. The results have implications for viral evolution and human disease.

MATERIALS AND METHODS {#SEC2}
=====================

Cell and virus culture {#SEC2-1}
----------------------

CCRF-SB human B lymphoblasts (a gift from Dr Jianzhu Chen, Singapore-MIT Alliance for Research and Technology) were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (FBS), 50 units/ml penicillin and 50 μg/ml streptomycin at 37°C and 5% CO~2~. The cells were collected by centrifugation at 350 *xg* for 10 min at 4°C. *Saccharomyces cerevisiae* strain W1588-4C (a gift from Dr Graham C. Walker, Massachusetts Institute of Technology) was grown exponentially in YPDA medium (1% yeast extract, 2% peptone, 2% dextrose, with 0.004% adenine hemisulfate) at 30°C with shaking at 200 rpm. The *Δndk* mutant strain of *Escherichia coli* W3110 was constructed by transduction using bacteriophage P1 vir. The mutant gene was obtained from the Keio Collection ([@B40]) in the form of a gene knockout carrying a kanamycin gene cartridge. The mutant gene was transduced into *E. coli* W3110 using a selection for kanamycin resistance. The resistance cartridge was then flipped out using flp sequences surrounding the kanamycin cartridge and flp recombinase supplied from the plasmid pCP20 ([@B41]). All *E. coli* strains were grown exponentially in LB broth at 37°C with shaking (220 rpm) to stationary phase. The cells were collected by centrifugation (4000 *xg* at 4°C) and washed once with ice-cold PBS. All cells were stored at −80°C until total RNA extraction. The DENV-2 strain TSV01 was prepared as described previously ([@B42]). Briefly, genome-length viral RNA (vRNA) was *in vitro* transcribed from full-length cDNA plasmid linearized by *ClaI*. The transcribed RNA is then electroporated into BHK-21 cells, the transfected cells were resuspended in 20 ml of DMEM medium and cultured at 30°C with 5% CO~2~ for 5 days to produce virus. The virus titer was measured by plaque assay. To purify virus particles, TSVOI was propagated in mosquito C6/36 cells. Briefly, C6/36 cells were infected with TSVOI at a multiplicity of infection (MOI) of 0.1 and incubated at 28°C for 4--5 days. Culture fluids were then harvested, virus particles were precipitated by 8% PEG8000 and purified through 10--30% potassium tartrate gradient. Purified viral particles *were* kept frozen at −80°C until use.

Methyl methanesulfonate treatment {#SEC2-2}
---------------------------------

Treatment of *S. cerevisiae* W1588-4C cells with 0.01% methyl methanesulfonate (MMS) was started when the O.D. of the cultures reached ∼0.17. After 3 h treatment, the cells were collected by centrifugation (4500 *xg* at 4°C) and washed once with ice-cold deionized water.

RNA extraction {#SEC2-3}
--------------

The total RNA from CCRF-SB pellets was directly extracted with Trizol reagent (Life Technologies), according to the manufacturer\'s protocol. For yeast and *E. coli*, lysis was performed with lyticase (Sigma) and lysozyme (Fluka), respectively, before total RNA was extracted with Trizol reagent as described earlier. Dengue virus genomic RNA was extracted from purified viral particles using Trizol reagent ([@B42]). The poly(A)-tailed RNA in human and yeast cells was isolated from the total RNA using a Fasttrack MAG Maxi mRNA isolation kit (Life Technologies) following the manufacturer\'s protocol. All RNA samples were used immediately or stored at −80°C.

Size-exclusion chromatography {#SEC2-4}
-----------------------------

The size-exclusion chromatography (SEC) of cellular total RNA and viral RNA was performed with a Bio SEC-5 1000 Å (i.d. 7.8 mm; length 300 mm), a Bio SEC3 300 Å (i.d. 7.8 mm, length 300 mm) or a Bio SEC-5 2000 Å (i.d. 7.8 mm; length 300 mm) column (Agilent Technologies), with 100 mM ammonium acetate as the mobile phase ([@B43]) (Supplementary Figure S1A). Isocratic separations were performed at 0.5 ml/min under partially denaturing conditions at 60°C on an Agilent 1200 HPLC system. The preliminary separations of cellular total RNA were performed on a Bio SEC-5 1000 Å column. Further separations (up to 3 rounds) of large rRNA: 28S and 18S rRNA for CCRF-SB, 25S and 18S rRNA for yeast, and 23S and 16S rRNA for *E. coli*; and small rRNA: 5.8S and/or 5S rRNA, and tRNA were performed on a Bio SEC-5 1000 Å and Bio SEC3 300 Å column, respectively. Separation of DENV-2 vRNA genome was performed with a Bio SEC-5 2000 Å column.

Analysis of purified RNA {#SEC2-5}
------------------------

The SEC-purified cellular and viral RNAs were concentrated and desalted with Amicon Ultracel 10k MWCO spin columns (Millipore). The quality of each RNA species was subsequently assessed using an Agilent Bioanalyzer (Agilent Technologies). RNA 6000 Nano or Pico chips were used to evaluate large cellular rRNA, poly(A) RNA and vRNA (Supplementary Figures S2A, S3A), whereas small rRNA and tRNA were evaluated on Small RNA chips (Supplementary Figure S4A).

RNA hydrolysis {#SEC2-6}
--------------

Isolated RNA (typically 5 μg) was incubated in 50 mM potassium hydroxide at 100°C for 40 min following a published protocol for quantitatively hydrolyzing RNA ([@B44]). The digestion mixture was then neutralized by addition of acetic acid. Subsequent dephosphorylation was carried out by addition of 20 μl of 100 mM Tris-HCl (pH 8.0) and 20 U of bacterial alkaline phosphatase (BAP; Invitrogen) at 37°C for 2 h. The enzymes were then removed by extraction with chloroform:isoamyl alcohol 24:1 (Fluka). The matrix in the aqueous layer was removed by solid-phase extraction with Strata-X polymeric reversed phase cartridges (Phenomenex), washing with 1 ml of deinoized water and subsequent elution with 3 ml of methanol. The eluate was concentrated and subjected to LC-MS/MS analysis. Using CCRF-SB 28S rRNA as substrate, the alkaline hydrolysis efficiency was assessed and BAP concentration optimized by quantifying canonical ribonucleosides with reversed-phase HPLC (Supplementary Figure S5A). Technical duplicates were performed.

LC-MS/MS analysis of dNrN {#SEC2-7}
-------------------------

Using synthetic standards (Midland Certified Reagent Company, Texas, USA), we defined the retention times for the set of all 16 possible dNrN dinucleotides on a Thermo Hypersil GOLD aQ column (100 × 1 mm, 3 μm) mounted in an Agilent 1200 capillary HPLC system that was coupled to an Agilent 6460 triple quadrupole mass spectrometer. The elution was conducted at 25°C and a flow rate of 8 μl/min, with a gradient of 100% buffer A (0.1% formic acid in water) and 0% buffer B (0.1% formic acid in methanol) for 5 min, followed by 0% to 40% buffer B over a period of 40 min. The mass spectrometer was operated with an electrospray ionization source in positive mode with the following parameters: gas temperature, 300°C; gas flow, 10 l/min; nebulizer, 40 psi; sheath gas temperature, 200°C; sheath gas flow, 7 l/min; and capillary voltage, 4000 V. Dynamic multiple reaction monitoring (MRM) mode was used for detection of product ions derived from the precursor ions for all 16 dNrN dinucleotides (see Supplementary Figure S6A for the MS/MS spectra) and 4 canonical nucleosides, with all instrument parameters optimized for maximal sensitivity for dNrN dinucleotides only (retention time in min, precursor ion *m/z*, product ion *m/z*, fragmentor voltage, collision energy): dCrC, 29.3, 533, 112, 110 V, 29 V; dCrU, 30.6, 534, 112, 110 V, 9 V; dCrA, 31.2, 557, 136, 110 V, 26 V; dCrG, 30.1, 573, 152, 120 V, 35 V; dTrC, 35.8, 548, 112, 120 V, 13 V; dTrU, 35.4, 549, 97, 90 V, 33 V; dTrA, 35.6, 572, 136, 140 V, 26 V; dTrG, 34.3, 588, 152, 140 V, 35 V; dArC, 32.6, 557, 112, 110 V, 21 V; dArU, 33.1, 558, 136, 110 V, 13 V; dArA, 33.5, 581, 136, 110 V, 40 V; dArG, 31.7, 597, 152, 110 V, 35 V; dGrC, 32.6, 573, 112, 100 V, 29 V; dGrU, 33.8, 574, 152, 80 V, 5 V; dGrA, 33.0, 597, 136, 90 V, 33 V; dGrG, 32.2, 613, 152, 110 V, 29 V; rC, 9.9, 244, 112, 85 V, 10 V; rU, 15.2, 245, 113, 85 V, 10 V; rA, 23.2, 268, 136, 85 V, 10 V; rG, 24.9, 284, 152, 85 V, 10 V. Analysis of dNrN dinucleotides in human and *E. coli* RNA was performed on this instrument with the above settings, while an Agilent 6490 Triple Quad was used to analyze dNrN dinucleotides in yeast and DENV-2 RNA in MRM mode with the following parameters: gas temperature, 50°C; gas flow, 11 l/min; nebulizer, 20 psi; sheath gas temperature, 300°C; sheath gas flow, 12 l/min; fragmentor voltage, 380 V; and capillary voltage, 1800 V. A Thermo Hypersil GOLD aQ column (100 × 1 mm, 3 μm) coupled to an Agilent 1290 HPLC system and the mass spectrometer was used with the elution conducted at 25°C at a flow rate of 20 μl/min, with a gradient of 0% buffer B to 50% buffer B over a period of 25 min. The same molecular transitions were used for detection of all 16 possible dNrN dinucleotides and 4 canonical rNs, with all instrument parameters optimized for maximal sensitivity for the dNrN dinucleotides (retention time in min, collision energy): dCrC, 15.1, 32 V; dCrU, 15.3, 10 V; dCrA, 17.2, 30 V; dCrG, 16.6, 26 V; dTrC, 18.1, 24 V; dTrU, 17.8, 24 V; dTrA, 18.1, 32 V; dTrG, 17.4, 26 V; dArC, 16.7, 32 V; dArU, 16.7, 14 V; dArA, 17.2, 32 V; dArG, 16.6, 32 V; dGrC, 16.5, 32 V; dGrU, 17.0, 12 V; dGrA, 16.6, 32 V; dGrG, 16.3, 32 V; rC, 4.5, 10 V; rU, 5.3, 10 V; rA, 11.1, 10 V; rG, 11.8, 10 V.

RESULTS {#SEC3}
=======

Development of the alkaline hydrolysis LC-MS/MS method for dNrN analysis {#SEC3-1}
------------------------------------------------------------------------

To quantitatively define the extent of dN misincorporation into RNA, we developed a highly specific, sensitive and quantitative technique that combines alkaline hydrolysis to release dNrN dinucleotides for LC-MS/MS quantification. The method relies on the well established role of the 2′-OH in the alkaline hydrolysis of RNA, with the lack of a 2′-OH in DNA rendering it resistant to alkaline hydrolysis ([@B45],[@B46]). Alkaline hydrolysis of dN-containing RNA will thus yield a limit digest of dNrN dinucleotides with a 3′-terminal phosphate, along with 2′-*O*-methyl-rN-containing dinucleotides that are also alkali-resistant ([@B47]), and an abundance of canonical ribonucleoside 3′-monophosphates (Supplementary Figure S5A). To facilitate separation and detection in subsequent LC-MS/MS analysis, the 3′-phosphates were removed with BAP to afford a mixture of ribonucleosides and dNrN dinucleotides. The alkaline hydrolysis conditions used here have been shown to afford quantitative hydrolysis of RNA ([@B44]), which was borne out in analyses of human CCRF-SB 28S rRNA based on the full recovery of rNs after dephosphorylation (Supplementary Figure S5B and C). We also optimized BAP concentration for dephosphorylation of the nucleotides resulting from alkaline hydrolysis of RNA (Supplementary Figure S5C). Using synthetic dNrNs, we optimized the HPLC retention times (Figure [1](#F1){ref-type="fig"}) and collision-induced dissociation (CID) molecular transitions (Figure [1](#F1){ref-type="fig"}, Supplementary Figure S6) to achieve limits of detection for the 16 dNrNs ranging from 6 to 720 amol using an Agilent 6490 QQQ instrument and 0.2 to 11 fmol using an Agilent 6460 QQQ instrument (Supplementary Table S1). An analysis of *E. coli* W3110 23S rRNA shown in Supplementary Figure S7 demonstrates the identification of all dNrNs and rNs based on their specific CID molecular transitions and retention times relative to synthetic standards. Using external calibration curves to quantify individual dNrNs (Supplementary Figure S8), the LC-MS/MS method provided a highly precise approach to quantify misincorporation of dN into any RNA species and to assess stress-induced changes in the misincorporation.

![Analysis of dNrN dinucleotides by alkaline hydrolysis-LC-MS/MS. (**A**) Workflow for the method. (**B-F**) Illustration of the analytical method with *E. coli* W3110 23S rRNA, showing HPLC elution profiles and MS/MS transitions (X→Y) for (**B**) dCrN dinucleotides, (**C**) dTrN dinucleotides, (**D**) dArN dinucleotides, (**E**) dGrN dinucleotides and (**F**) canonical rNs.](gkw572fig1){#F1}

The frequency of dNs in eukaryotic, prokaryotic and viral RNA {#SEC3-2}
-------------------------------------------------------------

The first application of the dNrN analytical method involved quantification of dN in coding and non-coding RNAs from a range of organisms: human cells, *S. cerevisiae*, two *E. coli* strains and dengue virus. As context for interpreting the results of these analyses, we note in Table [2](#tbl2){ref-type="table"} that mRNA in eukaryotes is synthesized by RNA Pol II, with 3′ poly(A) tailing by poly(A) polymerase (PAP) and 3′ poly(U) tailing by poly(U) polymerase (PUP) or 3′ terminal uridylyl transferase (TUTase), while 28S (human), 25S rRNA (yeast), 18S and 5.8S rRNAs are synthesized by RNA Pol I, and 5S rRNA and tRNA are synthesized by RNA Pol III, with 5′ CCA tailing by tRNA nucleotidyltransferase (NTR). All RNAs in *E. coli* are synthesized by a single RNA polymerase (RNAP), while the dengue NS5 protein is the source of RNA polymerase activity in this virus (Table [2](#tbl2){ref-type="table"}).

###### Levels of dNs in cellular and viral RNA species^1^

  Organism                         RNA species   dC per 10^6^ nt   dT per 10^6^ nt   dA per 10^6^ nt   dG per 10^6^ nt   Total dN/10^6^ nt   Polymerase
  -------------------------------- ------------- ----------------- ----------------- ----------------- ----------------- ------------------- -----------------------
  Human CCRF-SB                    poly(A) RNA   2.1 ± 0.6         0.7 ± 0.5         5.3 ± 1.0         8.9 ± 1.4         17 ± 3.5            Pol II + PAP + TUTase
                                   28S rRNA      0.9 ± 0.2         0.2 ± 0.06        0.3 ± 0.06        1.1 ± 0.3         2.6 ± 0.6           Pol I
                                   18S rRNA      1.6 ± 0.6         0.2 ± 0.08        0.6 ± 0.1         1.0 ± 0.4         3.3 ± 1.3           Pol I
                                   5.8S rRNA     2.8 ± 0.8         0.5 ± 0.3         0.8 ± 0.3         1.2 ± 0.5         5.3 ± 1.8           Pol I
                                   5S rRNA       4.3 ± 0.6         0.6 ± 0.09        0.9 ± 0.3         5.3 ± 0.6         11 ± 2              Pol III
                                   tRNA          6.3 ± 1.4         1.0 ± 0.1         0.8 ± 0.3         2.4 ± 0.4         11 ± 2              Pol III + NTR
  *S. cerevisiae* W1588-4C         poly(A) RNA   12 ± 3            8.9 ± 2.1         2000 ± 950        1100 ± 440        3200 ± 1400         Pol II + PAP + TUTase
                                   25S rRNA      6.1 ± 2.8         16 ± 4            96 ± 18           132 ± 58          250 ± 83            Pol I + PAP
                                   18S rRNA      8.9 ± 1.9         12 ± 0.8          85 ± 5            55 ± 12           161 ± 20            Pol I + PAP
                                   5.8S rRNA     10 ± 3            4.6 ± 0.6         64 ± 5            87 ± 13           165 ± 21            Pol I + PAP
                                   5S rRNA       19 ± 4            6.7 ± 1.4         55 ± 8            96 ± 23           176 ± 36            Pol III + PAP
                                   tRNA          43 ± 11           17 ± 1            90 ± 13           128 ± 38          278 ± 63            Pol III + NTR + PAP
  *S. cerevisiae* W1588-4C + MMS   poly(A) RNA   23 ± 5            15 ± 2            1,200 ± 260       697 ± 169         2000 ± 440          Pol II + PAP + TUTase
                                   25S rRNA      32 ± 6            21 ± 4            90 ± 6            132 ± 16          276 ± 33            Pol I + PAP
                                   18S rRNA      26 ± 7            14 ± 2            100 ± 22          136 ± 16          276 ± 47            Pol I + PAP
                                   5.8S rRNA     26 ± 6            7.2 ± 1.4         64 ± 7            71 ± 13           168 ± 28            Pol I + PAP
                                   5S rRNA       47 ± 18           10 ± 2            50 ± 8            182 ± 79          290 ± 108           Pol III + PAP
                                   tRNA          157 ± 44          34 ± 5            116 ± 9           357 ± 57          663 ± 115           Pol III + NTR + PAP
  *E. coli* DH5α                   23S rRNA      31 ± 8            12 ± 2            9.9 ± 3.8         54 ± 13           108 ± 27            RNAP
                                   16S rRNA      19 ± 8            13 ± 5            11 ± 2            50 ± 23           93 ± 38             RNAP
                                   5S rRNA       24 ± 17           6.8 ± 5.2         10 ± 7            36 ± 18           76 ± 47             RNAP
                                   tRNA          32 ± 12           22 ± 4            12 ± 6            36 ± 10           101 ± 32            RNAP
  *E. coli* W3110                  23S rRNA      54 ± 5            6.3 ± 0.6         7.5 ± 0.7         44 ± 3            111 ± 9             RNAP
                                   16S rRNA      45 ± 8            5.0 ± 0.8         5.4 ± 1.3         37 ± 11           92 ± 21             RNAP
                                   5S rRNA       65 ± 14           5.3 ± 1.4         6.4 ± 1.0         41 ± 7            118 ± 23            RNAP
                                   tRNA          65 ± 7            7.2 ± 1.2         4.1 ± 1.2         31 ± 4            107 ± 14            RNAP
  *E. coli* W3110 *Δndk*           23S rRNA      203 ± 32          9.4 ± 0.7         5.1 ± 1.0         70 ± 19           288 ± 53            RNAP
                                   16S rRNA      167 ± 37          8.5 ± 0.9         5.4 ± 1.4         32 ± 4            213 ± 43            RNAP
                                   5S rRNA       345 ± 51          8.5 ± 2.0         8.0 ± 1.2         55 ± 7            416 ± 61            RNAP
                                   tRNA          157 ± 46          9.9 ± 2.6         3.5 ± 0.4         26 ± 5            196 ± 54            RNAP
  DENV-2 virus                     RNA genome    171 ± 36          39 ± 21           103 ± 31          455 ± 95          768 ± 183           RdRP

^1^Values (as dN per 10^6^ nt) represent mean ± SD for three independent cultures for all cell lines, and for three technical replicates of a single culture for DENV-2 virus. PAP, poly(A) polymerase; TUTase, 3′ terminal uridylyl transferase; NTR, tRNA nucleotidyltransferase.

The first analysis involved poly(A)-tailed RNA (mainly mRNA), rRNA and tRNA from cultured human lymphoblasts CCRF-SB (Figure [2A](#F2){ref-type="fig"}). The levels of dNrNs were found to range from ∼0.01−1.6 per 10^6^ rNs in the three rRNA species made by Pol I, with a similar patterns of dNrN frequency (Table [2](#tbl2){ref-type="table"}). In contrast, the Pol III-mediated 5S rRNA and tRNAs contain misincorporated dNs at levels ∼2- to 4-fold higher than the Pol I rRNAs. Interestingly, the patterns of dNrN frequency are similar for Pol I and Pol II rRNAs. On the other hand, while poly(A) RNA, comprised mainly of mRNA, has a slightly higher dN misincorporation than 5S rRNA and tRNA, it contains substantially more dArA and dGrA than other RNAs. This suggests that the high levels of these two dinucleotides derive from the poly(A) tails in mRNA, which is consistent with the relatively low discrimination of dATP and ATP by human PAPγ (hPAPγ) ([@B48]). Moreover, poly(A) tails in some human transcripts contain a high percentage of guanine ribonucleotides, such as β-actin mRNA and truncated and polyadenylated 28S rRNA ([@B49]). However, we are not certain about the contribution of more recently discovered PUP and TUTase to the burden of misincorparated dN into pol(A) tails ([@B50]--[@B54]). Several interesting trends are apparent when comparing all of the human RNA species, including the consistently high levels of dCrA, the highly variable levels of dGrU (e.g. 5S rRNA *versus* 28S rRNA) and the consistently low levels of dArU (Figure [2](#F2){ref-type="fig"}).

![Quantitation of dN misincorporation in coding and non-coding RNAs. dNrN dinucleotides were quantified by alkaline hydrolysis LC-MS/MS in different RNA species. (**A**) Human CCRF-SB cells: poly(A) RNA, rRNA and tRNA. (**B**) *E. coli* DH5α rRNA and tRNA. (**C**) DENV-2 virus RNA genome. Values represent mean ± SD for three independent cultures for CCRF-SB and DH5α, and for three technical replicates of a single culture for DENV-2.](gkw572fig2){#F2}

We next analyzed dN misincorporation into RNAs from *S. cerevisiae* and *E. coli* as well as the RNA genome of dengue virus type 2 (DENV-2), a member of the *Flavivirus* family. In *S. cerevisiae*, all rRNA and tRNA species contain similar levels of dNs (∼160−280 dN per 10^6^ rNs), which is an order-of-magnitude lower than the dN levels in poly(A) RNA (Figure [3A](#F3){ref-type="fig"}; Table [2](#tbl2){ref-type="table"}). These dN frequencies are generally one to two orders-of-magnitude higher than those in human RNA. Interestingly, all RNA species in *S. cerevisiae* share similar dNrN distribution patterns. For example, dArA and dGrA are enriched in all RNA species, especially in the poly(A) RNA (Figure [3A](#F3){ref-type="fig"}). This can be explained by several factors. First, *S. cerevisiae* PAP, like human PAP, can use 2′-dATP as a substrate, but more efficiently than human PAP ([@B55],[@B56]). Second, a small percentage of some rRNAs in *S. cerevisiae*, including 25S rRNA, contain poly(A) tails ([@B57]) and both guanine and uracil have been detected in the poly(A) tails of *S. cerevisiae* mRNA and 25S rRNA ([@B49]).

![Exposure to methyl methanesulfonate (MMS) increases dN misincorporation in RNA in *Saccharomyces cerevisiae*. dNrN dinucleotides were quantified by alkaline hydrolysis LC-MS/MS in different RNA species from yeast exposed to MMS. (**A**) poly(A) RNA. (**B**) 25S rRNA. (**C**) 18S rRNA. (**D**) 5.8S rRNA. (**E**) 5S rRNA. (**G**) tRNA. Values represent mean ± SD for three biological replicates. \* *P* \< 0.05, two-tailed unpaired Student\'s *t* test.](gkw572fig3){#F3}

The dN frequency and patterns of dNrNs are similar in all rRNA and tRNA species in *E. coli* DH5α W3110 (Figures [2B](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"}; Table [2](#tbl2){ref-type="table"}). This is not surprising in light of the fact that all rRNAs and tRNAs are synthesized by a single RNAP. Further, the dN frequency in both *E. coli* strains is an order-of-magnitude higher than that in human CCRF-SB cells and is comparable to that in *S. cerevisiae*. The dN frequency in the RNA genome of DENV-2 virus is remarkably high at ∼800 per 10^6^ rNs, with dG as the most abundant dN (Figure [2C](#F2){ref-type="fig"}; Table [2](#tbl2){ref-type="table"}).

![dNrN levels and dNTP/rNTP ratios in wild-type and *Δndk E. coli* W3110. dNTP/rNTP ratios in WT and *Δndk E. coli* W3110 strains were taken from Lu *et al*. ([@B33]). (**A**−**D**) dNrN levels in (**A**) 23S rRNA, (**B**) 16S rRNA, (**C**) 5S rRNA and (**D**) tRNA. Values represent mean ± SD for three independent cultures. \* and \*\* represent statistically significant increases and decreases, respectively; *P* \< 0.05, two-tailed unpaired Student\'s *t*-test. (**E**−**H**) Correlation between misincorporated dN and nucleotide pool concentrations. 'Relative dN': ratio of dNrN in RNA from *E. coli Δndk* to that in WT *E. coli*; 'Relative dNTP/rNTP': ratio of dNTP/rNTP in *E. coli Δndk* to that in WT *E. coli*: (**E**) 23S rRNA, (**F**) 16S rRNA, (**G**) 5S rRNA and (**H**) tRNA.](gkw572fig4){#F4}

Determinants of dN levels in RNA {#SEC3-3}
--------------------------------

Three major determinants of dN misincorporation into RNA are the type of RNA polymerase, the sequence context and the composition of the nucleotide pool. Regarding the role of the RNA polymerase, the data in Table [2](#tbl2){ref-type="table"} for variation in dN frequency in the different types of RNA and in different organisms correlates well with the *in vitro* discrimination efficiencies of bacterial, yeast and viral RNA polymerases ([@B14],[@B16],[@B36],[@B38]). To investigate the role of nucleotide pool composition in dN misincorporation frequency, we quantified dNrN levels in an *E. coli* strain lacking NDK, a key enzyme in the control of cellular concentrations of (d)NTPs. The (d)NTP pool in *ndk*-deficient *E. coli* strains has a significant increase in the dCTP concentration and a smaller decrease in dATP concentration ([@B32],[@B33]). As shown in Figure [4](#F4){ref-type="fig"}, while there were significant increases up to 1.7-fold in the levels of several dN misincorporated into the various RNA species, dC misincorporation increased by 2.4- to 5.3-fold in the bacteria lacking *ndk* (Figure [4](#F4){ref-type="fig"}; Supplementary Table S2). This is consistent with the greatly elevated level of dCTP in *Δndk E. coli* ([@B33]). There are parallel, but less consistent, decreases in dA content in the *ndk* mutant compared to the WT cells, possibly due to the decreases in dATP concentrations caused by loss of Ndk activity ([@B32],[@B33]). To further assess the role of nucleotide pool composition in dN misincorporation, we calculated the ratio of dNTPs to rNTPs for each dNTP--rNTP pair from the various nucleoside triphosphate pool concentrations determined by Liu *et al*. in wild-type and *Δndk E. coli* strains ([@B33]) (Supplementary Table S2) and plotted these ratios against the ratio of misincorporated dN in the *Δndk* cells relative to wild-type cells. As shown in Figure [4E](#F4){ref-type="fig"}--[H](#F4){ref-type="fig"}, there is a generally linear relationship between the level of dNTPs and the dN misincorporation frequency, which illustrates the importance of the nucleotide pool composition in misincorporation of dN into RNA.

To explore the effects of sequence context on dN misincorporation, we quantified the effect of the identity of the rN positioned 3′ to the misinserted dN on the level of the dN. Here, we calculated the relative abundance of each rNrN sequence in rRNAs in human, *S. cerevisiae*, and *E. coli* K-12 cells and in the RNA genome of DENV-2 virus (Supplementary Figure S9) and used these values to normalize the level of the corresponding dNrN (Figure [5](#F5){ref-type="fig"}). The normalized dNrN values (dNrN/rNrN) correct the absolute abundance of the misincorporated dN for the frequency of the corresponding rNrN motif in each type of RNA. Supplementary Table S3B shows Z-scores (i.e. the degree of deviation from the mean) that quantify biases the frequencies of the normalized dNrN values in each RNA species. A survey of the data reveals that dC is among the most frequently misincorporated dNs when the 3′ nucleotide is rA in all types of rRNA in human cells and *E. coli* (Figure [5A](#F5){ref-type="fig"}, [C](#F5){ref-type="fig"} and [D](#F5){ref-type="fig"}; Supplementary Table S3B), while dCrG is the most abundant context for dC misincorporation in DENV-2 (Figure [5E](#F5){ref-type="fig"}; Supplementary Table S3B). Similarly, dG is misincorporated frequently next to rA in rRNAs in yeast and *E. coli*. Interestingly, the two *E. coli* strains show significant differences in nearest neighbor effects on the misincorporation, as illustrated by the differences in dGrA and dGrG (Figure [5C](#F5){ref-type="fig"} and [D](#F5){ref-type="fig"}; Supplementary Table S3). In contrast, dArA, dGrA and dGrG dominate the purine misincorporation risk in yeast and dGrA in DENV-2 genome.

![dNrN frequencies normalized to rNrN occurrences in rRNAs and the DENV-2 RNA genome. The absolute abundance of dNrN was normalized by dividing by the frequency of the corresponding rNrN dinucleotide sequence in (**A**) human rRNAs (**B**) yeast rRNAs, (**C**) *E. coli* DH5α rRNAs, (**D**) *E. coli* W3110 rRNAs and (**E**) DENV-2 RNA genome. Values represent mean ± SD for either three biological or technical replicates. The values for dTrU in 5S rRNA are not shown in (C) and (D) because of the absence of rUrU in the reported sequence of *E. coli* 5S rRNA.](gkw572fig5){#F5}

The next question concerned the relative roles of nucleotide pool concentration and local sequence context in determining polymerase-induced dN misincorporation. If dN misincorporation is driven only by nucleotide pool concentration, then the normalized data in Figure [5](#F5){ref-type="fig"} should be identically proportional to the absolute dNrN levels in Figure [2](#F2){ref-type="fig"}. However, if some sequence contexts affect the polymerase misincorporation more than others, then there should be a discrepancy between the absolute dNrN value and the rNrN-normalized data in relation to other sequence contexts. This is illustrated by visual comparisons of absolute dNrN values in Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} to the sequence-normalized values in Figure [5](#F5){ref-type="fig"}, which reveals sequence context effects that vary according to the organism and the RNA polymerase. For example, dCrG and dCrA have similar absolute levels in DENV-2 RNA (Figure [2C](#F2){ref-type="fig"}), while the normalized value for dCrG is 4- to 5-fold higher than that for dCrA (Figure [5D](#F5){ref-type="fig"}). This shows that DENV-2 NS5 polymerase is sensitive to sequence context in selectively incorporating dC next to rG. To address this problem quantitatively across all sequence contexts, we calculated Z-scores for the various dNrN values in each RNA species in Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} and plotted these scores against the Z-scores for the associated dNrN/rNrN values. The resulting plots shown in Supplementary Figure S10 reveal that, by and large, the magnitude of the normalized misincorporation frequency correlates directly with the absolute level for a dNrN, which is consistent with a stronger influence of polymerase than sequence context on dN misincorporation. However, Supplementary Figure S10 also shows that there are several clear deviations from this relationship, such as the dCrG and dCrA context effects in DENV-2 and dGrG in human 28S rRNA, which point to a strong influence of sequence context on dN insertion. Overall, the results point to varying and significant influences by the RNA polymerase, the nucleotide pool composition and the sequence context as determinants of dN frequency *in vivo*.

Stress-induced misincorporation of dNs into RNA {#SEC3-4}
-----------------------------------------------

The studies with *Δndk E. coli* revealed an important role for nucleotide pool imbalances in the frequency of dN misincorporation into RNA. We next sought to assess dN misincorporation in a eukaryotic system based on stress-induced changes in the nucleotide pool. Ribonucleotide reductases (RNR) play a central role in dNTP synthesis and altered RNR activity has been shown to cause large, mutagenic changes in dNTP levels in the nucleotide pool ([@B31],[@B42],[@B58],[@B59]). Since Begley and coworkers have demonstrated significant up-regulation of RNR activity in yeast exposed to MMS ([@B32],[@B35]), we sought to quantify the effects of MMS exposure on dN levels in *S. cerevisiae* RNA. As shown in Figure [3](#F3){ref-type="fig"}, MMS treatment caused a significant ∼2- to ∼3-fold increase in dN misincorporation in all RNA species examined, including poly(A) RNA, rRNAs and tRNA. dC and dT were the most consistently affected across all RNA species with increases also noted for some dA and dG misincorporations.

DISCUSSION {#SEC4}
==========

By combining alkaline hydrolysis with LC-MS/MS analysis, we were able to develop a highly specific and sensitive method to identify and quantify dN misincorporation in any type of RNA. Application of this method to human cells, yeast, bacteria and an RNA virus has provided the first quantitative insights into the *in vivo* contributions of nucleotide pool balance, RNA polymerase and local sequence context as determinants of dN misincorporation in RNA, and then how stress disrupts these factors to alter misincorporation. The frequency of dN misincorporation into RNA at ∼1 per 10^5^ nucleotides in mammalian cells parallels other forms of RNA damage, such as 8-oxoguanosine (10^−5^/nt), 1,N^6^-ethenoadenosine (10^−8^/nt) and xanthosine (10^−7^/nt) ([@B60]). The results have implications for eukaryotic and prokaryotic pathophysiology and viral evolution.

This highly specific method utilizes the selective hydrolysis of rNs in RNA under alkaline conditions, which allows the dNs in RNA to be liberated as dNrN dinucleotides. Thus, the presence of contaminating DNA in the purified RNA species, which is inevitable and would obviously lead to artifacts in quantifying dNs in RNA in nuclease-based approaches, would not affect dN quantification using our approach. In the analysis of the released dNrNs, it is important to keep in mind that alkaline hydrolysis of RNA containing 2′-O-methylated ribonucleotides also produces dinucleotides containing the methylated ribonucleotide at the 5′-end, which protects the phosphodiester bond from cleavage the same way the lack of a 2′-OH does in dNrN. Previous attempts to quantify dN misincorporation in RNA have involved *in vitro* analyses using gel shift, *in vitro* transcription, or radiolabel incorporation assays that provide information on the rNTP/dNTP discrimination efficiencies for RNA polymerases ([@B14],[@B16],[@B36]--[@B38]). The major limitation of the alkaline hydrolysis/LC-MS/MS assay is the loss of other sequence context information for the misincorporated dN. One possible approach to mapping these dN in RNA is to use limited hydrolysis at alkaline pH to nick RNA at each ribonucleotide, with the misincorporated dN and 2′-O-methylated ribonucleotides protected from hydrolysis. Reverse transcription using a hybridized primer or a primer to a ligated linker, with subsequent sequencing analysis, would produce a one-nucleotide resolution ladder of RNA fragments lacking the protected site ([@B47]).

While *in vitro* studies predicted that the identity of the RNA polymerase and the relative concentrations of nucleotide pool components would affect the *in vivo* frequency and identity of misincorporated dNs in RNA ([@B14],[@B16],[@B36]--[@B38]), the role of RNA sequence context in dN insertion emerges here as a significant complicating factor in understanding the dN misincorporation phenomenon. The results of the *in vivo* analyses presented here establish that both polymerase and pool factors contribute to the dN misincorporation, with a surprisingly large range of misincorporation frequencies in different organisms (Table [2](#tbl2){ref-type="table"}) and very significant biases in both the identity of the misincorporated dN and its location in terms of nearest neighbor. Indeed, the relative differences in dN frequencies among different RNA species in the human, yeast and bacterial cells are consistent with the discrimination efficiencies established *in vitro* for the different types of RNA polymerases in each organism ([@B14],[@B16],[@B36]--[@B38],[@B61]). Similarly, our observation of a general increase in dN misincorporation frequency in moving from eukaryotic cells to bacteria to viruses is also consistent with species-specific RNA polymerase behaviors determined *in vitro* ([@B14],[@B16],[@B36]--[@B38],[@B61]). As a matter awaiting further study, the molecular basis for biased dN incorporation due to sequence context may arise from both local primary or secondary RNA structural influences.

The high rate of misincorporation of dNs into the RNA genome of DENV-2 (Table [2](#tbl2){ref-type="table"}) suggests a potential mechanism that contributes to the high frequency of mutations in RNA-based viruses. Mutation serves as an adaptive mechanism for RNA viruses during infections and can increase viral pathogenicity, with the magnitude of detrimental or lethal effects of the mutations mitigated by mechanisms that confer mutational robustness (i.e. the ability to buffer mutational effects on phenotype) ([@B62]). In general, RNA viruses have high mutation rates, with rates of substitution mutations ranging from 10^−6^ to 10^−4^ per nucleotide per cell infection ([@B63]) and ∼2% sequence variation among viruses in the same host during an infection(64). The main driver of this high mutation rate is likely the error-prone nature of the NS5 RNA-dependent RNA polymerase ([@B65]). While it is unclear to what extent the RNA-dependent RNA polymerase selects the wrong RTP (direct mutation) or misinserts a dNTP (indirect mutation), the exceptionally high dN frequency in the DENV-2 RNA genome---∼7 dN in ∼11 000 nt (∼10^−3^/nt)---likely contributes to polymerase infidelity, which is supported by recent structure-function studies ([@B66]). RNA-dependent RNA polymerases have been shown to copy DNA templates albeit with significantly lower efficiency and with evidence for a requirement of 2′-OH groups at positions near the transcription start site ([@B67]). While further study is needed to define the relative contributions of the sugar and base mispairing in viral mutagenesis, dNs in RNA may also contribute to viral evolution by mechanisms other than single-nucleotide substitution. It is well established that premature termination and pausing of the RNA polymerase or reverse transcriptase can trigger RNA recombination ([@B68]). Given that dN in an RNA template can cause pausing/premature termination during viral transcription, viral RNA genome replication and reverse transcription ([@B15],[@B25]--[@B29]) and dN misincorporated into nascent RNA during viral RNA synthesis impedes further extension ([@B15]), it is possible that dNs in RNA can contribute to RNA recombination. Additionally, dN misincorporation in RNA may contribute to low genome GC content in RNA-based viruses ([@B69]). This is supported by the large bias (by 5.8-fold) in dC+dG incorporation over dT+dA incorporation in DENV-2 genome (Figure [5E](#F5){ref-type="fig"}). dN misincorporation in RNA may also contribute to the repression of CpG usage in RNA-based viruses ([@B69]), with dCrG as the most abundant context for dNrN errors and rCrG as the most under-represented dinucleotide in the DENV-2 genome (Figure [5E](#F5){ref-type="fig"}, Supplementary Figure S9D). dNs in RNA may thus play a role in the evolution of genome compression and genome novelty of RNA-based viruses ([@B70]).

As illustrated here with the *E. coli Δndk* mutant, the composition of the nucleotide pool plays a significant role in the risk of inserting dN into RNA, with effects likely to be felt in all organisms, including viruses. The stress imposed by viral infection of a human cell may be associated with shifts in nucleotide pool balance that favor dN incorporation into replicating viral RNA genomes. The nucleotide pool imbalance could compound the high error rates of viral RNA-dependent RNA polymerases to further increase the rate of viral mutagenesis. The 10-fold higher concentrations of rNTPs than dNTPs in the intracellular nucleotide pool ([@B3]) also likely account for the fact that the frequency of dN in RNA in yeast (this study) is lower than the misincorporation of rN into DNA observed by Kunkel *et al*. ([@B2]). Again, cell stress can alter the nucleotide pool balance and thus alter dN and rN misincorporations. The genes encoding RNR, a protein that is key to dNTP synthesis in all organisms and tightly regulates pool dNTP concentrations, are inducible at the level of transcription in all organisms, including *E. coli, S. cerevisiae* and humans, by agents that damage DNA, such as UV light and MMS, or by agents that block DNA synthesis ([@B58]). This is consistent with our observation that MMS treatment results in increased levels of dNs in coding and non-coding RNA species in *S. cerevisiae* (Figure [3](#F3){ref-type="fig"}).

Viral RNA-dependent RNA polymerases are far more error-prone than eukaryotic DNA-dependent RNA polymerases, likely due to the absence of several polymerase-specific mechanisms to control fidelity. For example, RNA PolII in yeast has a 'trigger loop' that contributes significantly to the discrimination between NTPs and dNTPs ([@B13]). Once incorporated into the nascent RNA, dNs often inhibit further extension of RNA transcripts *in vitro* for both cellular and viral RNA polymerases ([@B14]--[@B16]). However, successful elongation past dN leads to a relatively stable transcript. The nucleolytic proofreading activity of eukaryotic RNA polymerases ([@B71]) appears to be more sensitive to base pairing incompatibility rather than sugar identity, with RNA polymerases removing incorporated dNs with an incorrect base *in vitro* as efficiently as incorporated rNs with the same incorrect base ([@B72]). This suggests that incorporated dNs with the correct base may not be subject to removal by RNA polymerases and further that most, if not all, dNs present in cellular RNA have the correct base. Indeed, the level of base misincorporations in bacterial and eukaryotic RNA species is estimated to be around 10^−5^ per nt or lower ([@B71]), which is approximately one order-of-magnitude lower than the dN frequencies in various coding and noncoding RNA species in bacteria and yeast (Table [2](#tbl2){ref-type="table"}).

The consequences of dN misincorporation into RNA involve translational errors in all organisms and mutations in viral RNA genomes. The presence of a single dN in mRNA can cause mis-translation in the form of truncation of the peptide at a frequency of 30% to 50% ([@B10],[@B64],[@B66]). The dN likely also causes miscoding and insertion of the incorrect amino acid, as do many other RNA modifications such as m^5^C ([@B64]), though the effect of dNs on translational recoding has not received significant attention. The potential for a link between dN misincorporation into RNA and human diseases is apparent in studies demonstrating markedly elevated (up to ∼2000-fold) dNTP concentrations in human immunodevelopment diseases caused by inherited deficiencies in enzymes responsible for the salvage or degradation of dNTPs ([@B73],[@B74]). It has also been established that poly(A) tail length contributes to translational regulation and is implicated in a number of physiological and pathological processes ([@B75]). Given that incorporation of dNs into the poly(A) tails of RNA by PAP can inhibit further tail extension ([@B55]), it is possible that variation in poly(A) tail lengths may be driven by dN incorporation. For example, we observed higher dN levels in poly(A) RNA in yeast compared to humans, which correlated with the shorter mean poly(A) tail length in yeast than in human cells ([@B76]). Interestingly, recent studies showed that uridylation occurs on oligoadenylated mRNAs in yeast, *Arabidopsis* and human cells ([@B50]--[@B52]). TUTases selectively insert UTP over the other NTPs ([@B53]), however it remains unknown if 2′-dNTPs are substrates of TUTases although crystal structures suggest that they can discriminate ribose sugar against 2′-deoxyribose sugar ([@B54]).

Our results suggest that dNs in RNA are present at appreciable levels in all organisms, with strong dependence on the RNA polymerase, nucleotide pool balance and environmental stresses. The analytical method developed here will find utility in defining the relationship between misincorporation of dN in RNA and biological endpoints such as disease pathophysiology and viral evolution.
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